TWD
RIGL icon

True Wealth Design’s Rigel Pharmaceuticals RIGL Stock Holding History

True Wealth Design’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.45K Buy
30
+2
+7% +$87 ﹤0.01% 1801
2026
Q2 		$1.1K Hold
28
– – ﹤0.01% 1945
2026
Q1 		$758 Sell
28
-1
-3% -$34 ﹤0.01% 1904
2025
Q4 		$1.24K Buy
29
+1
+4% +$38 ﹤0.01% 1633
2025
Q3 		$794 Hold
28
– – ﹤0.01% 1833
2025
Q2 		$525 Buy
+28
New +$531 ﹤0.01% 1723

Other funds holding RIGL

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Venture Visionary Partners
Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design's RIGL Position: Q3 2026 in Review

True Wealth Design increased its Rigel Pharmaceuticals (RIGL) stake by 7.1% in Q3 2026, buying an estimated $87 and bringing the position to 30 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

True Wealth Design first reported a position in RIGL in Q2 2025 and has held it in 6 quarters since. 10 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • True Wealth Design held 30 shares of Rigel Pharmaceuticals worth $1.45K as of Q3 2026.
  • True Wealth Design bought 2 Rigel Pharmaceuticals shares in Q3 2026, an estimated $87.
  • Rigel Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1801 holding.
  • True Wealth Design first reported a position in Rigel Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 10 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.